Skip to main content


Figure 3 | Cancer Cell International

Figure 3

From: The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis

Figure 3

Effects of ATO and nilotinib on hemoglobin content. Cells were treated with 1 μM ATO and 5 nM nilotinib alone or in combination for 72 h. Then, cell samples were stained with benzidine. (A) The percentage of benzidine-positive cells was calculated. **P < 0.01 vs. control. (B) Representative data of benzidine staining (x200 magnification).

Back to article page